These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3187292)

  • 41. Renal cell carcinoma: progress against an elusive tumor.
    Motzer RJ
    Semin Oncol; 2000 Apr; 27(2):113-4. PubMed ID: 10768590
    [No Abstract]   [Full Text] [Related]  

  • 42. The failure of infarction and/or nephrectomy in stage IV renal cell cancer to influence survival or metastatic regression.
    Flanigan RC
    Urol Clin North Am; 1987 Nov; 14(4):757-62. PubMed ID: 3314066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose interleukin-2 in the therapy of metastatic renal-cell carcinoma.
    Parkinson DR; Sznol M
    Semin Oncol; 1995 Feb; 22(1):61-6. PubMed ID: 7855620
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

  • 45. [Phase II trial of treatment of metastatic renal adenocarcinoma with recombinant leukocyte interferon (rDNA IFN-alpha 2)].
    Dorval T; Palangie T; Garcia-Giralt E; Jouve M; Bretaudeau B; Falcoff F; Coninx P; Schwab D; Pouillart P
    Bull Cancer; 1985; 72(5):470-1. PubMed ID: 4074917
    [No Abstract]   [Full Text] [Related]  

  • 46. [A case of renal cell carcinoma effectively treated by interferon-alpha and embolization of the renal artery].
    Tsujimura A; Imazu T; Nishimura K; Sugao H; Oka T; Takaha M; Takeda M; Kurata A
    Hinyokika Kiyo; 1993 Nov; 39(11):1039-42. PubMed ID: 8266872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
    Atzpodien J; Kirchner H; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical treatment options in patients with metastatic renal cell carcinoma.
    Haferkamp A; Hohenfellner M
    Nephrol Dial Transplant; 2007 Apr; 22(4):996-9. PubMed ID: 17210591
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
    Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
    Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.
    Small EJ; Weiss GR; Malik UK; Walther PJ; Johnson D; Wilding G; Kuzel T; Bajamonde A; Paton V
    Cancer J Sci Am; 1998; 4(3):162-7. PubMed ID: 9612597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The problem of attempted suicide in accordance with guidelines of the German Society for Humane Dying].
    Köppel C; Barckow D; Grüneberg F; Schneider V
    Med Klin (Munich); 1991 Aug; 86(8):429-31. PubMed ID: 1717816
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotherapy of metastatic renal cell cancer.
    Goey SH; Verweij J; Stoter G
    Ann Oncol; 1996 Nov; 7(9):887-900. PubMed ID: 9006738
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hypernephroma--recent development during clinical approach].
    Levin I; Fulga V; Klein B
    Harefuah; 1989 Apr; 116(8):429-32. PubMed ID: 2663675
    [No Abstract]   [Full Text] [Related]  

  • 57. [New developments in the treatment of metastatic renal carcinoma].
    Sabbatini R; Ferrari A; Pagano M; Conte PF
    Tumori; 2008; 94(6):Suppl 9-18. PubMed ID: 19267117
    [No Abstract]   [Full Text] [Related]  

  • 58. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.
    Poon DM; Chan CK; Chan K; Chu WH; Kwong PW; Lam W; Law KS; Lee EK; Liu PL; Sze HC; Wong JH; Chan ES
    Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():27-38. PubMed ID: 33860644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A urologic perspective on management of localized and metastatic RCC.
    Jain S; Alter RS; Sawczuk I
    Oncology (Williston Park); 2012 Jun; 26(6):537. PubMed ID: 22870538
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal cell carcinoma.
    deKernion JB
    J Urol; 1986 Oct; 136(4):882. PubMed ID: 3761450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.